|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
7
|
|
gptkbp:bfsParent
|
gptkb:Famotidine
|
|
gptkbp:activities
|
H2 receptor antagonist
|
|
gptkbp:brand
|
gptkb:Pepcid
|
|
gptkbp:category
|
B
|
|
gptkbp:child
|
gptkb:battle
|
|
gptkbp:clinical_trial
|
FDA approval
Safety profile assessment
Efficacy in treating GERD
|
|
gptkbp:community_service
|
gptkb:battle
|
|
gptkbp:contraindication
|
Severe renal impairment
Hypersensitivity to famotidine
|
|
gptkbp:counseling_services
|
Store in a cool, dry place
Take as directed
Shake well before use
Do not exceed recommended dose
Report any unusual symptoms to a doctor
|
|
gptkbp:dosage_form
|
gptkb:item
|
|
gptkbp:duration
|
10 to 12 hours
|
|
gptkbp:form
|
30 mg/5 m L
40 mg/5 m L
|
|
gptkbp:formulation
|
Suspension
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pepcid Oral Suspension
|
|
gptkbp:ingredients
|
gptkb:Famotidine
|
|
gptkbp:interacts_with
|
gptkb:Ketoconazole
gptkb:Warfarin
gptkb:Atazanavir
Antacids
|
|
gptkbp:is_used_for
|
gptkb:Zollinger-Ellison_syndrome
Gastroesophageal reflux disease (GERD)
Peptic ulcers
|
|
gptkbp:manager
|
Oral
|
|
gptkbp:manufacturer
|
gptkb:Various
|
|
gptkbp:premiered_on
|
1 hour
|
|
gptkbp:requires
|
Prescription required
|
|
gptkbp:shelf_life
|
24 months
|
|
gptkbp:side_effect
|
gptkb:Nausea
Diarrhea
Dizziness
Headache
Constipation
|
|
gptkbp:social_structure
|
C8 H10 N4 O2 S
|
|
gptkbp:storage
|
Room temperature
Protect from light
|
|
gptkbp:symptoms
|
Confusion
Hallucinations
Bradycardia
Hypotension
Severe dizziness
|